SPOT 36™ Endoscopic Marker

Product Code / Ordering Information

Item No Title Quantity
GIS-44E Spot 36 Box of 10

The original, safer, no-mess endoscopic tattoo. Spot 36 is clinically proven effective for marking lesions in both the upper and lower GI tract and Spot 36 contains no known carcinogens and/or shellacs.

Spot 36 is clinically proven to effectively mark lesions throughout the entire GI tract. Our proprietary carbon black tattooing ink is the simply clean, simply effective, simply smarter choice.

Complete: Spot 36 can be put to work in the upper and lower GI tract.
Clean: Spot 36 is premixed to reduce the risk of spills and stains.
Safe: Spot 36 is proven safe for permanent endoscopic tattooing with over 40 million uses to date. Spot’s pre-loaded syringe contains no known carcinogens or shellacs
Fast: Spot 36 is ready to use after thoroughly shaking the pre-loaded syringe.
Trusted: Spot 36 is permanent when injected into the submucosal tissue. On follow-up endoscopy or surgery, Spot’s marking will be there.
Sterile: Spot’s pre-loaded syringe contents are provided sterile.

FDA Cleared: Spot 36 is the only non-India-ink-based product for marking lesions in the GI tract cleared by the U.S. Food and Drug Administration.

Clinical Reference

  • Clinical Study Be certain. Be exact. “The exact location of the tumour is crucial for undertaking minimal invasive surgery. This can be difficult because of the lack of tactile sensation and if size of lesion is small. Surgery time may be prolonged if the tumour site is doubtful, and the potential risk of complications increases. Endoscopic Spot make the surgeon certain of the exact tumour site and reduces the risk of removal of the wrong segment of the small intestine.”
    Nina A, Orhan B. Endoscopic tattooing of small bowel by double – balloon endoscopy. J Dig Endosc 2013;4:49-51
  • Article Take the time to be more accurate. The authors believe this tattooing method yields more accurate distal margins than can be obtained using standard methods. Confidence that the margin obtained will be oncologically adequate removes the uncertainty that otherwise often accompanies this part of the operation.”
  • Kirchoff DD, Hang JH, Cekic V, Baxter K, Kumar P, Shehebar J, Holzman K, Whelan RL. Endoscopic Tattooing to Mark Distal Margin for Low Anterior Rectal and Select Sigmoid Resections. Surg Innov 2013 Oct 30 [Epub ahead of print]
  • Article Proven Safe. The safety and efficacy of Spot 36 were evaluated in a study of 113 patients…At operation, the tattoos were visible in all cases, and none of the resected specimens exhibited necrosis or abscess formation on histopathology.”
  • ASGE Technology Committee. Technology Status Evaluation Report: Endoscopic tattooing. Gastrointest Endosc. 2010 Oct;72(4):681-5. doi: 10.1016/j.gie.2010.06.020.
  • Article Sterile and Safe “Commercially available India Ink has been used by endoscopists to mark or tattoo lesions for subsequent surgery or endoscopy since 1975. A new endoscopic marker has been developed. It is sterile and pre-diluted and is devoid of clinical side effects. It should replace commercial India Ink which contains shellac, phenol, ammonia, and other unknown and proprietary chemicals.”
  • Fiedler L.M., Waye J.D., Harpaz N., Janowitz D. The Disappearance of India Ink. Gastrointest Endosc. 2000 Apr;51:4:2 AB272.